已發(fā)表的部分文獻: 標題:Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.作者:Rao JS, Keleshian VL, Klein S, Rapoport SI;雜志名稱:Transl Psychiatry 標題:Silent information regulator 1 protects the brain against cerebral ischemic damage.作者:Hernández-Jiménez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I, Moro MA;雜志名稱:Stroke 標題:An improved method for the derivation of high quality iPSCs in the absence of c-Myc.作者:Habib O, Habib G, Choi HW, Hong KS, Do JT, Moon SH, Chung HM;雜志名稱:Exp Cell Res 標題:Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.作者:Yamanishi M, Narazaki H, Asano T;雜志名稱:Exp Hematol 標題:Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2.作者:Saini M, Selokar NL, Agrawal H, Singla SK, Chauhan MS, Manik RS, Palta P;雜志名稱:Reprod Fertil Dev 標題:Effects of Wutou Decoction on DNA Methylation and Histone Modifications in Rats with Collagen-Induced Arthritis作者:Liu Y, Wen C, Chen Z, Wang Y, Huang Y, Hu Y, Tu S;雜志名稱:Evid. Based Complement. Alternat. Med. 標題:Aberrant histone modification and inflammatory cytokine production of peripheral CD4+ T cells in patients with oral lichen planus.作者:Shen J, Yin C, Jiang X, Wang X, Yang S, Song G;雜志名稱:J Oral Pathol Med 標題:Epigenetic Immunomodulatory Effect of Eugenol and Astaxanthin on Doxorubicin Cytotoxicity in Hormonal Positive Breast Cancer Cells作者:Fouad M, et. al.;雜志名稱:BMC Pharmacology & Toxicology Epigentek 公司是全球領先的表觀遺傳學相關研究的技術創(chuàng)新者和產(chǎn)品開發(fā)供應商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。